Lionheart Health to Showcase Regenerative Technology at Octane Medical Innovation Forum

Lionheart Health, Inc. will present its innovative technology platform at the 2025 Octane Medical Innovation Forum focused on The Science of Longevity, scheduled for October 28th and 29th in Irvine, California. The forum brings together industry experts, entrepreneurs, investors and thought leaders for two days of learning, networking and innovation on the latest medical industry trends. Howard Leonhardt, Executive Chairman and co-Chief Executive Officer of Lionheart Health, will present the company's latest developments in regenerative aesthetics and healthspan longevity technologies.

The company's first-in-class technology platform utilizes precise patented bioelectric signaling sequences to trigger the release of regeneration-promoting proteins on demand. This includes controlled expression of klotho, a protein identified as a key component in aging management. One patented signaling sequence controls stem cell recruitment, proliferation and differentiation as needed. The technology's significance lies in its potential to address fundamental aging processes at the cellular level, representing a novel approach to longevity science.

Lionheart Health's business model involves licensing and supporting clinics worldwide with its patented technology platform in exclusive territories. Currently operating one clinic in Newport Beach, California and seven other licensed locations, the company aims to establish 124 licensed sites within the next 60 months. This expansion strategy demonstrates the commercial viability and growing demand for regenerative medicine technologies in the healthcare market. The company maintains an online presence at http://www.lionhearthealthstim.com where interested parties can learn more about their services.

The company's technological achievements have garnered significant recognition within the medical community. Earlier this year, Lionheart Health was named a top 40 semi-finalist in the XPRIZE Healthspan Competition out of 600 entries, focusing on improvements in muscle health, brain health and immunity health with the goal of increasing healthy living years by 20 years. Additional recent accolades include recognition from Medtech Outlook Magazine for Top Micro Stimulator Implant Development of 2025 and finalist status in both the Orange County Business Journal's Innovator of the Year Award and the Octane High Tech Awards in the Medical Innovation category.

Perhaps the most ambitious project under development is Lionheart Health's whole body regeneration chamber, described as a womb for adults. The company is currently building and testing prototypes, with plans to release an initial version utilizing only non-invasive technologies, followed by an advanced version incorporating robotics, artificial intelligence and implantable pump and stimulation technologies for internal organ regeneration. This project represents a significant leap forward in regenerative medicine capabilities. The company collaborates with various research institutions, including maintaining a long-standing residency at University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab in Irvine.

Recent partnerships further strengthen Lionheart Health's technological position, including a special collaboration with CoreViva for AI-enhanced MRI diagnostics. The company's research efforts have been supported through multiple UCI Capstone Grants, including funding for Brain Band TM, its bioelectric stimulation technology platform for brain health. These developments position Lionheart Health at the forefront of the rapidly evolving longevity medicine field, with potential implications for treating age-related diseases and extending healthy human lifespan. Additional information about the company's research initiatives can be found at http://www.leonhardtventures.com.